Search results for "staging"

showing 10 items of 740 documents

Nationwide Analysis on Surgical Staging Procedures and Systemic Treatment for Patients With Endometrial Cancer in Germany

2012

ObjectiveIn 2009 and 2006, the Arbeitsgemeinschaft Gynäkologische Onkologie evaluated therapeutic approaches for endometrial carcinoma (EC) in Germany.Methods and MaterialsA questionnaire was developed and sent to 775 German gynecologic departments in 2009 (500 in 2006). The results of the questionnaires were compared with each other and with the recommendations of the Arbeitsgemeinschaft Gynäkologische Onkologie’s guideline. Subgroup analyses were performed, dividing the participating centers into small and large centers and into centers with less and more experience with EC.ResultsResponses were available in 33.3% in 2009 and 35.8% in 2006. Comparing 2009 with 2006, it became apparent tha…

medicine.medical_specialtyGynecologic oncologySurgical stagingGynecologic Surgical ProceduresGermanySurveys and QuestionnairesCytologyAntineoplastic Combined Chemotherapy ProtocolsmedicineCarcinomaHumansMulticenter Studies as TopicPelvic lymphadenectomyDiagnostic Techniques Obstetrical and GynecologicalNeoplasm StagingGynecologybusiness.industryData CollectionGeneral surgeryEndometrial cancerObstetrics and GynecologyProfessional PracticeGuidelinemedicine.diseaseHospitalsPeritoneal washingEndometrial NeoplasmsOncologyLymph Node ExcisionFemaleGuideline AdherencebusinessCarcinoma EndometrioidInternational Journal of Gynecologic Cancer
researchProduct

The Treatment of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Systematic Review with a Pooled Analysis of Only Surgery versus Combined Prot…

2021

Medication-related osteonecrosis of the jaw (MRONJ) is a serious adverse reaction of antiresorptive and antiangiogenic agents, and it is also a potentially painful and debilitating condition. To date, no specific studies have prospectively evaluated the efficacy of its treatment and no robust standard of care has been established. Therefore, a systematic review (2007–2020) with a pooled analysis was performed in order to compare MRONJ surgical techniques (conservative or aggressive) versus combined surgical procedures (surgery plus a non-invasive procedure), where 1137 patients were included in the pooled analysis. A statistically significant difference in the 6-month improvement rate, comp…

medicine.medical_specialtyHealth Toxicology and Mutagenesismedicine.medical_treatmentONJReviewsurgerymedicineHumansAdverse effectONJ Osteonecrosis Staging Surgery Therapy TreatmenttherapyONJ; Osteonecrosis; Staging; Surgery; Therapy; Treatment; Bisphosphonate-Associated Osteonecrosis of the Jaw; Diphosphonates; Humans; Bone Density Conservation AgentsDiphosphonatesBone Density Conservation Agentstreatmentbusiness.industryosteonecrosisSignificant differenceBlood componentRPublic Health Environmental and Occupational HealthstagingSurgical proceduresmedicine.diseaseSurgeryPooled analysisImprovement rateMedicineBisphosphonate-Associated Osteonecrosis of the JawOsteonecrosis of the jawbusinessAdjuvantInternational Journal of Environmental Research and Public Health
researchProduct

Staging and follow-up of patients with melanoma: which tests for which patients?

2013

medicine.medical_specialtyHistologySkin Neoplasmsbusiness.industryDiagnostic Tests RoutineMelanomaDermatologymedicine.diseasePathology and Forensic MedicineMedicineHumansRadiologybusinessMelanomaFollow-Up StudiesNeoplasm Staging
researchProduct

Transperitoneal versus extraperitoneal laparoscopic aortic lymph nodal staging for locally advanced cervical cancer: A systematic review and meta-ana…

2021

Abstract Cervical cancer is the fourth most common neoplasm in women. In locally advanced cervical cancers, the international guidelines recommend nodal aortic assessment. Two techniques have been described to perform laparoscopic aortic lymphadenectomy: transperitoneal laparoscopic lymphadenectomy (TLL) and extraperitoneal laparoscopic lymphadenectomy (ELL). This meta-analysis aims to compare the surgical outcomes of TLL and ELL for staging purposes. The systematic review was carried out in agreement with the preferred reporting items for systematic reviews and meta-analyses statement (PRISMA). Two hundred and twenty studies were analyzed, and 19 studies were included in the review (7 for …

medicine.medical_specialtyIntraoperative Complicationmedicine.medical_treatmentUterine Cervical Neoplasms03 medical and health sciencesPostoperative Complications0302 clinical medicineExtraperitonealLaparotomyAortic lymphadenectomymedicineHumansMinimally invasiveIntraoperative ComplicationsLymph nodeAortaNeoplasm StagingCervical cancerUterine Cervical Neoplasms...030219 obstetrics & reproductive medicinebusiness.industryPostoperative complicationGeneral Medicinemedicine.diseaseSurgeryLaparoscopic stagingmedicine.anatomical_structureOncology030220 oncology & carcinogenesisMeta-analysisLymph Node ExcisionFemaleLaparoscopySurgeryLymphadenectomyLymph NodesLymphPeritoneumbusinessEuropean Journal of Surgical Oncology
researchProduct

Multiparametric MRI and Radiomics in Prostate Cancer: A Review of the Current Literature

2021

Prostate cancer (PCa) represents the fourth most common cancer and the fifth leading cause of cancer death of men worldwide. Multiparametric MRI (mp-MRI) has high sensitivity and specificity in the detection of PCa, and it is currently the most widely used imaging technique for tumor localization and cancer staging. mp-MRI plays a key role in risk stratification of naïve patients, in active surveillance for low-risk patients, and in monitoring recurrence after definitive therapy. Radiomics is an emerging and promising tool which allows a quantitative tumor evaluation from radiological images via conversion of digital images into mineable high-dimensional data. The purpose of radiomics is to…

medicine.medical_specialtyMedicine (General)Clinical BiochemistryReviewProstate cancerR5-920RadiomicsProstatemedicinemagnetic resonance imagingcancerGleason scoreCancer stagingPI-RADSprostatemedicine.diagnostic_testbusiness.industryCancerMultiparametric MRIMagnetic resonance imagingmedicine.diseasePI-RADSmedicine.anatomical_structureradiomicsRadiologybusinessSettore MED/36 - Diagnostica Per Immagini E RadioterapiaDiagnostics
researchProduct

2020

Background External validation of prognostic risk models is essential before they are implemented in clinical practice. This study evaluated the recently developed MEGNA score for survival prediction after resection of intrahepatic cholangiocarcinoma (ICC), with a focus on the direct comparison of its prognostic value to that of the current International Union Against Cancer (UICC)/American Joint Committee on Cancer (AJCC) Cancer staging system. Material and methods Between 1997 and 2018, 417 consecutive patients with ICC were referred to our tertiary care centre and were retrospectively identified out of a dedicated clinical database. Of this group, 203 patients underwent surgical resectio…

medicine.medical_specialtyMultidisciplinarybusiness.industrymedicine.medical_treatmentConcordanceRetrospective cohort studyLog-rank test03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisInternal medicinePredictive value of testsmedicine030211 gastroenterology & hepatologyLymphadenectomybusinessSurvival analysisCancer stagingCohort studyPLOS ONE
researchProduct

Monofocal hepatocellular carcinoma: How much does size matter?

2020

Background & Aims: According to the Barcelona Clinic Liver Cancer (BCLC) staging system, monofocal hepatocellular carcinoma (HCC) is classified as early (BCLC A) irrespective of its size, even though controversies still exist regarding staging and treatment of large tumours. We aimed at evaluating the appropriate staging and treatment for large (>5 cm) monofocal (HCC). Methods: From the Italian Liver Cancer database, we selected 924 patients with small early monofocal HCC (2-5 cm; SEM-HCC), 163 patients with larger tumours (>5 cm; LEM-HCC) and 1048 intermediate stage patients (BCLC B). Results: LEM-HCC patients had a worse overall survival (OS) than SEM-HCC (31.0 vs 49.0 months; P…

medicine.medical_specialtyMultivariate analysisCarcinoma HepatocellularIndependent predictorGastroenterologyResection03 medical and health sciences0302 clinical medicineInternal medicinemedicineOverall survivalHepatectomyHumansStaging systemNeoplasm StagingRetrospective StudiesSettore MED/12 - GastroenterologiaHepatologytreatmentbusiness.industrySettore MED/09 - MEDICINA INTERNALiver Neoplasmsbclc staging systemmonofocal hepatocellular carcinomamedicine.diseasedigestive system diseasesSurvival benefitItaly030220 oncology & carcinogenesisHepatocellular carcinomabclc staging system; liver resection; monofocal hepatocellular carcinoma; prognosis; treatmentliver resection030211 gastroenterology & hepatologyprognosisbusinessLiver cancerprognosi
researchProduct

Octreotide for malignant bowel obstruction: Twenty years after

2012

Malignant bowel obstruction (MBO) is a challenging complication of advanced cancer. Conservative treatment of inoperable MBO in terminal cancer patients has been found to be effective in controlling the distressing symptoms caused by this complication in inoperable cancer patients. Twenty years ago, octreotide was proposed to treat symptoms related to malignant bowel obstruction. Since then several reports have confirmed the efficacy of octreotide in the management of gastrointestinal symptoms of MBO. Fifteen randomized controlled trials or observational reports with a significant number of patients treated with octreotide have been reviewed; 281 patients were surveyed. Authors reported a t…

medicine.medical_specialtyOctreotideOctreotidelaw.inventionGastrointestinal AgentsRandomized controlled triallawNeoplasmsHumansMedicineNeoplasm StagingGastrointestinal agentbusiness.industryCancerHematologymedicine.diseaseAdvanced cancerSurgeryBowel obstructionTreatment OutcomeOncologyObservational studybusinessComplicationIntestinal Obstructionmedicine.drugCritical Reviews in Oncology/Hematology
researchProduct

Esophageal cancer: Clinical Practice Guidelines for diagnosis, treatment and follow-up

2010

Esophageal cancer: Clinical Practice Guidelines for diagnosis, treatment and follow-up M. Stahl, W. Budach, H.-J. Meyer & A. Cervantes On behalf of the ESMO Guidelines Working Group* Department of Medical Oncology and Centre of Palliative Care, Kliniken Essen-Mitte, Essen; Department of Radiation Oncology, University of Dusseldorf, Dusseldorf; Department of Surgery, Stadt Klinikum Solingen, Germany; Department of Hematology and Medical Oncology, INCLIVA, University of Valencia, Valencia, Spain

medicine.medical_specialtyPalliative careEsophageal NeoplasmsMeta-Analysis as TopicRadiation oncologymedicineHumansNeoplasm MetastasisNeoplasm StagingEsophageal diseasebusiness.industryIncidenceGeneral surgeryFollow up studiesCancerHematologyEsophageal cancermedicine.diseasehumanitiesSurgeryEsophagectomyEuropeClinical PracticeTreatment OutcomeClinical Trials Phase III as TopicOncologyDiagnosis treatmentEsophagoscopybusinessFollow-Up StudiesAnnals of Oncology
researchProduct

Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

2010

Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up A. Okines, M. Verheij, W. Allum, D. Cunningham & A. Cervantes On behalf of the ESMO Guidelines Working Group* GI Clinical Trials Unit, Royal Marsden Hospital, Sutton, UK; Department of Radiation Oncology and Division of Cellular Biochemistry, The Netherlands Cancer Institute—Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Surgery, Royal Marsden Hospital, London; Department of Medicine, Royal Marsden Hospital, Sutton, UK; Department of Hematology and Medical Oncology, INCLIVA, University of Valencia, Valencia, Spain

medicine.medical_specialtyPalliative careTreatment outcomeMeta-Analysis as TopicStomach NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsGastroscopyRadiation oncologyEpidemiologymedicineHumansNeoplasm MetastasisNeoplasm StagingRandomized Controlled Trials as TopicRadiotherapybusiness.industryIncidenceGeneral surgeryPalliative CareCancerHematologymedicine.diseaseCombined Modality TherapySurvival AnalysishumanitiesSurgeryEuropeClinical PracticeTreatment OutcomeOncologyClinical trials unitDiagnosis treatmentChemotherapy AdjuvantbusinessFollow-Up StudiesAnnals of Oncology
researchProduct